CT Features of Ovarian Tumors: Defining Key Differences Between Serous Borderline Tumors and Low-Grade Serous Carcinomas-Reference-Cited by-同舟云学术

CT Features of Ovarian Tumors: Defining Key Differences Between Serous Borderline Tumors and Low-Grade Serous Carcinomas

Published:2018-04 Issue:4 Volume:210 Page:918-926
ISSN:0361-803X
Container-title:American Journal of Roentgenology
language:en
Short-container-title:American Journal of Roentgenology

Author:

Nougaret Stephanie¹²³,Lakhman Yulia²,Molinari Nicolas⁴,Feier Diana²⁵,Scelzo Chiara²⁶,Vargas Hebert A.²,Sosa Ramon E.²,Hricak Hedvig²,Soslow Robert A.⁷,Grisham Rachel N.⁸,Sala Evis²

Affiliation:

1. Service de Radiologie, Institut Régional du Cancer de Montpellier, 208 Avenue des Apothicaires, Montpellier, Herault 34298, France.

2. Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY.

3. Institut de Recherche en Cancérologie de Montpellier, University of Montpellier, Montpellier, France.

4. Department of Statistics, Centre Hospitalier Universitaire de Montpellier, University of Montpellier, Montpellier, France.

5. Department of Radiology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.

6. Department of Surgery, Gynecology and Obstetrics Section, Tor Vergata University, Rome, Italy.

7. Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY.

8. Department of Medicine, Gynecologic Medical Oncology Service, Weill Cornell Medical College, New York, NY.

Publisher

American Roentgen Ray Society

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Link

https://www.ajronline.org/doi/pdf/10.2214/AJR.17.18254

Reference32 articles.

1. Borderline ovarian tumour: pathological diagnostic dilemma and risk factors for invasive or lethal recurrence

2. A multistep model for ovarian tumorigenesis: the value of mutation analysis in theKRAS andBRAF genes

3. The Recurrence and the Overall Survival Rates of Ovarian Serous Borderline Neoplasms With Noninvasive Implants is Time Dependent

4. BRAF Mutation is associated with early stage disease and improved outcome in patients with low-grade serous ovarian cancer

5. Mutations in BRAF and KRAS Characterize the Development of Low-Grade Ovarian Serous Carcinoma

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Convergence of Radiology and Genomics: Advancing Breast Cancer Diagnosis with Radiogenomics;Cancers;2024-03-06

2. Radiomics nomogram for preoperative differentiation of early-stage serous borderline ovarian tumors and serous malignant ovarian tumors;Frontiers in Oncology;2024-01-15

3. Exploring the impact of surgical interventions and identifying risk factors for recurrence in stage I of borderline ovarian tumors;European Journal of Gynaecological Oncology;2024

4. Role of magnetic resonance imaging to differentiate between borderline and malignant serous epithelial ovarian tumors;Abdominal Radiology;2023-10-20

5. Comprehensive Review of Serous Tumors of Tubo-Ovarian Origin: Clinical Behavior, Pathological Correlation, Current Molecular Updates, and Imaging Manifestations;Current Problems in Diagnostic Radiology;2023-09